Menu Mobile
Aguarde Carregando

VII International Symposium on Translational Oncology

Imagem do Evento: VII International Symposium on Translational Oncology
✪ Local: Medical School - Facisb | Barretos, SP - Brazil
Por:
Escolha a categoria
Código do evento: 74

VII International Symposium on Translational Oncology
Categoria do evento

The Institute of Research of Education of  Barretos Cancer Hospital (HCB) brings together the Molecular Oncology Research Center (CPOM), Clinical Research Unit (UPC) and Post-Graduation in Oncology, leading the ground of precision oncology. CPOM is an advanced molecular oncology research center based on the most modern research centers in the world, providing access to technological resources and laboratories for molecular genetics, cellular biology, and animal models, with integrated facilities that allow the development of cutting-edge research projects.

In order to continue its mission of training and disseminating among researchers, oncologists, residents, postgraduate students, and other health professionals the main updated oncological topics, HCB is organizing the VII International Symposium on Translational Oncology at the Barretos Cancer Hospital. This event, organized by researchers and oncologists of the institute, aims to promote discussion and interaction between the target public and researchers of national and international recognition, who develop their work in centers of excellence in the various areas of oncology, which will contribute to the consolidation and improvement of translational medicine and clinical research in oncology nationally and internationally.

Program

09/13/2019 (Friday)

07:00 am – 07:30 am | Registration
07:30 am – 07:40 am | Opening and Welcome
Rui Manuel Reis, PhD (Barretos Cancer Hospital, Barretos, Brazil) Scientific Director

07:40 am – 09:40 am | Session 1
Hereditary Cancer and genetic risk factors

Discussion Leaders: Dirce Maria Carraro,PhD / Rui Manuel Reis, PhD

07:40 am – 08:10 am |  Genetic analyses of a demographically defined population reveals new ovarian cancer predisposing gene candidates
Speaker: Patrizia Tonin, PhD (McGill University Health Centre, Montreal, Canada) 

08:10 am 08:40 am | Deciphering genetic susceptibility to lung cancer
Speaker: James McKay, PhD ( IARC, Lyon, France) 

08:40 am 09:10 am | The germline mutation landscape of Hereditary Breast Cancer in Brazil
Speaker: Edenir Inez Palmero, PhD (Barretos Cancer Hospital, Barretos, Brazil) 

09:10 am – 09:40 am | Discussion

09:40 am – 10:10 am | Coffee-break 

10:10 am – 12:10 am | Session 2
Early detection and cancer screening

Discussion Leaders: Denise Peixoto Guimarães, MD, PhD / José Humberto T. G. Fregnani, MD,PhD 

10:10 am – 10:40 am | The wide effect of microbiota on cancer
Speaker: Christian Jobin, MD, PhD (University of Florida, Gainesville, Florida)

10:40 am – 11:10 am | What tools do we have to eliminate cervical cancer?
Speaker:
Luisa Lina Villa, PhD ( Instituto do Câncer do Estado de São Paulo, São Paulo, Brazil) 

11:10 am – 11:40 pm | Translational research in cancer screening at Barretos Cancer Hospital
Speaker: Ana Carolina de Carvalho Peters, PhD (Barretos Cancer Hospital, Barretos, Brazil) 

11:40 am – 12:10 pm |  Discussion

12:10 pm – 12:40 pm |  Technical lecture - SOPHIA GENETICS SA

12:40 pm – 2:10 pm | Lunch

2:10 pm – 2:55 pm | Oral presentation of Best Abstracts
Discussion Leader: Jeremy Andrew Squire, PhD 

2:10 pm – 2:20 pm |

2:20 pm – 2:30 pm |

2:30 pm – 2:40 pm |

2:40 pm – 2:55 pm | Discussion

2:55 pm – 4:55 pm – Session 3
Environmental factors and Exposome in cancer development

Discussion Leaders: Henrique Silveira, PhD / Fabiana de Lima Vazquez, PhD

2:55 pm – 3:25 pm – Etiological factors influence differences and consequences in lipid bodies formation between obese and non-obese associated esophageal tumors
Speaker: Luis Felipe Ribeiro Pinto, PhD (National Cancer Institute – INCA, Rio de Janeiro, Brazil) 

3:25 pm – 3:55 pmExploring interactions between the exposome and cancer through metabolomics – Application to cohort studies
Speaker: Augustin Scalbert, PhD (International Agency for Research on Cancer - IARC, Lyon, France) 

3:55 pm – 4:25 pmLong term exposure assessment to urban air pollution: an autopsy based study
Speaker: Paulo Hilário Nascimento Saldiva, MD, PhD (Universidade de São Paulo, Instituto de Estudos Avançados USP, São Paulo, Brazil) 

4:25 pm – 4:55 pm - Discussion

4:55 pm – 6:55 pm – Session 4
Molecular biomarkers in translational oncology

Discussion Leaders: Patricia Reis, PhD  / Márcia Maria C. Silveira, PhD

4:55 pm – 5:25 pm –  Clonal hematopoiesis and malignant clonal evolution
Speaker:
Rodrigo Calado, MD, PhD ( (FMRP/USP, Ribeirão Preto, Brazil) 

5:25 pm – 5:55 pm – Alterations of DNA methylation as biomarkers in tumors from the upper aerodigestive tract
Speaker:
Sheila Coelho Soares Lima, PhD (National Cancer Institute – INCA, Rio de Janeiro, Brazil) 

5:55pm – 6:25pmThe Molecular Landscape of Brazilian Lung Cancer: Searching for Clinically Relevant Biomarkers
Speaker:
Letícia Ferro Leal, PhD (Barretos Cancer Hospital, Barretos, Brazil) 

6:25pm – 6:55pm – Discussion

6:55pm - 8:55pm - Happy hour and visit to the posters
 

09/14/2019 (Saturday)


07:30 am – 09:30 am – Session 5
Personalized Medicine

Discussion Leaders: Vinícius de Lima Vazquez, MD, PhD / Jeremy Andrew Squire, PhD 

07:30 am – 08:00 amRaf Kinase Inhibitory Protein (RKIP): a new predictor of EGFR targeted therapy response in solid tumors?
Speaker: Olga Martinho,  PhD (University of Minho, Portugal)

08:00 am – 08:30 amThe Brazilian Initiative on Precision Medicine (BIPMed): contributions of the past four years
Speaker:
Iscia Lopes Centes, PhD ( UNICAMP, Campinas, Brazil) 

08:30 am – 09:00 am –  GBM: a fatal tumor  and its perpetual stem cells
Speaker: Vivaldo Moura Neto, PhD (Instituto Estadual do Cérebro Paulo Niemeyer, Rio de Janeiro, Brazil)

09:00 am – 09:30 am – Discussion

09:30 am – 10:00 am – Coffee-break 

10:00 am – 12:00 pm – Session 6
Innovative approaches for cancer discovery and treatment

Discussion Leaders: Osvaldo Novais de Oliveira Jr, PhD / Matias Eliseo Melendez, PhD

10:00 am – 10:30 am Oncolytic herpes simplex virus for cancer therapy
Speaker: 
Samuel D. Rabkin, PhD (Massachusetts General Hospital & Harvard Medical School, Boston, USA)

10:30 am – 11:00 am – The use of multi-omic data integration to reveal potential targets in HPV-related cancers
Speaker:
Marcelo Alves Soares, PhD (National Cancer Institute – INCA, Rio de Janeiro, Brazil)

11:00 am – 11:30 amMechanism of action of combi-molecules rationally designed to block multiple adverse signalling pathways and reverse MGMT-mediated resistance: relevance to immuno-oncology
Speaker: Bertrand Jean Claude, PhD (University McGill, Montreal, Canada) 

11:30 am – 12:00 pm – Discussion

12:00 pm – 12:30 pm –  Analysis of immune checkpoints with IHC: the importance of validation in the right application and the establishment of multiplexed IHC assays
Speaker: Jonah Riddell, PhD - Cell Signaling Technology

12:30 pm – 02:00 pm – Lunch

02:00 pm – 04:00 pm – Session 7
Immunotherapy and tumor microenvironment

Discussion Leaders: Céline Marques Pinheiro, PhD / Flávio Cárcano, MD, PhD

02:00 pm – 02:30 pm –  Lactate and acidification represent metabolic checkpoints in the tumor environment
Speaker:
Marina Kreutz, PhD ( University Hospital Regensburg, Regensburg, Alemanha)

02:30 pm – 03:00 pm – Systemic and tissue immune networks to identify novel targets and therapy response markers in cancer
Speaker: Kenneth Gollob, PhD (AC Camargo Cancer Center, São Paulo, Brazil)

03:00 pm – 03:30 pm –  Cross talk between STAT3 and NFkB underlies immune evasion mechanisms in cervical cancer
Speaker:  Ana Paula Lepique,PhD  (University of São Paulo – São Paulo, Brazil)

03:30 pm – 04:00 pm – Discussion

04:00 pm – 06:00 pm – Session 8
Experimental models in translational oncology

Discussion Leaders: Carlos Alberto Scrideli, MD, PhD / Silvia Teixeira, PhD

04:00 pm –04:30 pm – Zika virus: from enemy  to ally
Speaker:
Mayana Zatz, PhD (University of São Paulo – São Paulo, Brazil) 

04:30 pm – 05:00 pm – Exploiting viruses for the treatment of brain tumors 
Speaker: Sean Edward Lawler, PhD (Brigham and Women's Hospital – Harvard Medical School - Boston, USA) 

05:00 pm – 05:30 pm – Immune cell therapies for cancer: future promises and challenges
Speaker:
Mohan Sobhana Nandhu, PhD (Takeda Pharmaceutical International Co, Cambridge, USA) 

05:30 pm – 06:00 pm – Discussion

06:00 pm – 06:10 pm – Awards of the best oral presentation and poster
Discussion Leader:

06:00 pm – 06:10 pm – Closing remarks

 

Committee

Executive and Scientific Committee

Ana Carolina Carvalho
Adriane Evangelista Feijó
Céline Marques Pinheiro
Denise Guimarães
Edenir Inez Palmero
Fabiana Vazquez
Flávio Cárcano 
Henrique Cesar Santejo Silveira
Letícia Ferro Leal
Luis Fernando Lopes
Márcia Maria Chiquitelli Marques Silveira
Mariana Tomazini Pinto
Matias Melendez
Pedro de Marchi
Ricardo dos Reis
Rui Manuel Vieira Reis
Silvia Teixeira
Vinícius de Lima Vazquez
Vinicius Duval da Silva
Viviane Aline Saito

 

Organizing Committee

Bianca Cristina Pereira
Camila Argolo Muniz
Caio Fernando de Oliveira
Dorion Denardi
Joyce Silva Pinto

Registration Fees

Health professionals and PhD – R$ 350,00

Graduate students – R$ 250,00

Undergraduate students – R$ 150,00

Employees from Barretos Cancer Hospital - R$ 150,00

Cancellation deadline of  Inscription - seven days

Confirmed International and National Speakers

Augustin Scalbert, PhD
IARC – Lyon, France.

https://www.iarc.fr/staff_member/dr-augustin-scalbert/


Bertrand Jean Claude, PhD
MC Gill University, Montreal – Canadá.

https://www.mcgill.ca/expmed/dr-bertrand-jean-claude


Christian Jobin, MD, PhD
University of Florida, Gainesville – Florida, USA.

https://gastroliver.medicine.ufl.edu/about-us/meet-the-team/christian-jobin-ph-d/


James Mckay, PhD
IARC – Lyon, France.

https://www.iarc.fr/staff_member/dr-james-mckay/


Mohan Sobhana Nandhu, MD, PhD
State University of New York Upstate Medical University – New York, USA

https://www.researchgate.net/profile/Mohan_Sobhana_Nandhu


Patrizia Tonin, PhD
MC Gill University – Montreal, Canadá.

http://rimuhc.ca/-/patricia-tonin


Sean Edward Lawler, PhD
Brigham and Women's Hospital – Boston, USA

https://connects.catalyst.harvard.edu/Profiles/display/Person/78460


Marina Kreutz, PhD
University Hospital Regensburg - Regensburg, Alemanha
https://www.researchgate.net/profile/Marina_Kreutz2


Samuel D. Rablin
Massachusetts General Hospital & Harvard Medical School - Boston, USA

http://www.dfhcc.harvard.edu/insider/member-detail/member/samuel-d-rabkin-phd/


Ana Carolina de Carvalho Peters, PhD
Barretos Cancer Hospital - Barretos, Brazil
http://lattes.cnpq.br/0525201717724232


Edenir Inez Palmero, PhD
Barretos Cancer Hospital - Barretos, Brazil

http://lattes.cnpq.br/4094427750209083


Iscia Teresinha Lopes Cendes
UNICAMP - Campinas, Brazil

http://lattes.cnpq.br/3944020856408245


Kenneth John Gollob , PhD
AC Camargo Cancer Center - São Paulo, Brazil

http://lattes.cnpq.br/4314074851986989


Letícia Ferro Leal, PhD
Barretos Cancer Hospital - Barretos, Brazil

http://lattes.cnpq.br/4142456089656080


Luis Felipe Ribeiro Pinto, PhD
National Cancer Institute – INCA - Rio de Janeiro, Brazil

http://lattes.cnpq.br/0774809439237135


Luisa Lina Villa, PhD
Instituto do Câncer do Estado de São Paulo - São Paulo, Brazil

http://lattes.cnpq.br/8379358682656422


Marcelo Alves Soares, PhD
National Cancer Institute – INCA - Rio de Janeiro, Brazil

http://lattes.cnpq.br/7635170597670838


Mayana Zatz, PhD
Universidade de São Paulo – USP - São Paulo, Brazil

http://lattes.cnpq.br/2454447846752426


Paulo Hilário Nascimento Saldiva, MD, PhD
Universidade de São Paulo, Instituto de Estudos Avançados – USP - São Paulo, Brazil

http://lattes.cnpq.br/5450805572417395


Rodrigo do Tocantins Calado De Saloma Rodrigues, PhD
Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo – USP - Ribeirão Preto, Brazil

http://lattes.cnpq.br/5187902541390363


Sheila Coelho Soares Lima, PhD
National Cancer Institute – INCA - Rio de Janeiro, Brazil

http://lattes.cnpq.br/7690812849140276


Vivaldo Moura Neto, PhD
Instituto Estadual do Cérebro Paulo Niemeyer, Centro de Estudo e Pesquisa, Laboratório de Biomedicina do Cérebro

http://lattes.cnpq.br/4692980070480625


 

 

 

Submit Abstract

 

CRITÉRIOS PARA APRESENTAÇÃO DOS TRABALHO
PRAZO PARA SUBMISSÃO DOS RESUMOS: 20/04/2019 A 31/07/2019

1. Seleção dos resumos

Todos os resumos submetidos serão avaliados pela comissão científica. Os candidatos selecionados serão convidados a apresentar seus trabalhos em formato de pôster durante a sessão de pôsteres. Os três melhores resumos, de acordo com os critérios de seleção (item 2), serão indicados para a apresentação na modalidade oral. Os resumos submetidos ao simpósio deverão ser fundamentados no tema do simpósio (oncologia translacional).

2. Critérios de seleção dos resumos

a) Originalidade científica, qualidade e relevância temática do trabalho ao tema do evento;
b) Resumo conciso, clareza na apresentação das ideias e com conclusões pertinentes.

3. Instruções para o envio de resumos

Os resumos devem ser apresentados em inglês, letra no estilo Times New Roman, tamanho 12, espaçamento 1,5 e alinhamento Justificado.
O resumo deve incluir o Título, nome(s) e afiliação(ões) dos autores e deve ser estruturado, sendo dividido da seguinte forma: Introdução, Objetivos, Materiais e Métodos, Resultados, Conclusões e palavras-chave (mínimo de 3 e máximo de 5 palavras). O resumo deve ter no máximo 250 palavras (sem contar o título, nomes e afiliações).
Pelo menos um autor do trabalho deve estar inscrito no evento como participante e deve ser o apresentador do trabalho. As inscrições para o evento estão disponíveis em nosso site: http://oncoeventos.com.br/evento/74-vii-international-symposium-on-translational-oncology

4. Instruções para a confecção de pôsteres

O pôster deverá confeccionado e apresentado em inglês. O espaço destinado ao pôster será de 2 metros de altura por 1 metro de largura (na orientação retrato). Você pode preencher esse espaço como desejar, entretanto o tamanho recomendado para o seu cartaz é de 90 cm de largura e 120 cm de altura, na orientação retrato. Os pôsteres devem ser fixados antes do início da programação do dia da apresentação.

5. Instruções para as apresentações orais

A apresentação oral deverá ser em inglês com duração máxima de 10 minutos seguido de arguição por banca examinadora. Serão penalizadas as apresentações que não respeitarem o tempo estipulado. As apresentações devem ser entregues ao suporte de media desk antes do início da programação do dia da apresentação.

6. Premiação Modalidade: apresentação oral

Para ser elegível para o prêmio, OBRIGATORIAMENTE o primeiro autor deverá ser o apresentador do trabalho. O primeiro colocado será premiado como melhor trabalho na modalidade apresentação oral e o segundo lugar receberá uma menção honrosa na mesma modalidade.

Modalidade: Pôster

Para ser elegível para o prêmio, OBRIGATORIAMENTE o apresentador deverá ser autor/co-autor do trabalho. O primeiro colocado será premiado como melhor trabalho na modalidade pôster e o segundo lugar receberá uma menção honrosa na mesma modalidade.

 

Sponsors | Support

Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

       

 

 


 

Support

 

 

 

 

 

Todos direitos reservados © 1999 - 2019 Hospital de Câncer de Barretos.